Keywords: overseas, sales, lift, synthelabo, nine, month, results
Overseas Sales Lift Synthelabo Nine Month Results
Article | 14 November 1994
Synthelabo, which says it is France's third largest pharmaceutical group, achieved sales of 5.96 billion French francs ($1.26 billion) for the first ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
